Human papillomavirus type 33 polymorphisms and high-grade squamous intraepithelial lesions of the uterine cervix

Journal of Infectious Diseases

Volumn 194, Issue 7, 2006, Pages 886-894

  Khouadri, Soraya ^a   Villa, Luisa L ^e   Gagnon, Simon ^a   Koushik, Anita ^d   Richardson, Harriet ^d   Ferreira, Silvaneide ^e   Tellier, Pierre ^d   Simao, João ^e   Matlashewski, Greg ^d   Roger, Michel ^b,c   Franco, Eduardo L ^d   Coutlée, Francois ^a,b,c,d  

^a Centre de Recherche   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN E6; PROTEIN E7;

ADULT; ARTICLE; BINDING SITE; BRAZIL; CANADA; CANCER GRADING; CARCINOGENESIS; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GEOGRAPHY; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX CANCER;

EID: 33749030202     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/507431     Document Type: Article

References (45)

1. Ferenczy A, Franco EL. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol 2002; 3:11-6.
2. Hildesheim A, Wang SS. Host and viral genetics and risk of cervical cancer: a review. Virus Res 2002; 89:229-40.
3. Bernard HU, Calleja-Macias IE, Dunn ST. Genome variation of human papillomavirus types: phylogenetic and medical implications. Int J Cancer 2006; 118:1071-6.
4. Villa LL, Sichero L, Rahal P, et al. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 2000; 81:2959-68.
5. Giannoudis A, Herrington CS. Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol 2001; 193:295-302.
6. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology 2004; 324:17-27.
7. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003; 88:63-73.
8. Clifford GM, Smith JS, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003; 89:101-5.
9. Gagnon S, Hankins C, Tremblay C, Forest P, Pourreaux K, Coutlee F. Viral polymorphism in human papillomavirus types 33 and 35 and persistent and transient infection in the genital tract of women. J Infect Dis 2004; 190:1575-85.
10. Tran-Thanh D, Provencher D, Koushik A, et al. Herpes simplex virus type II (HSV-2) is not a cofactor to human papillomavirus in cancer of the uterine cervix. Am J Obstet Gynecol 2003; 188:129-34.
11. Koushik A, Ghosh A, Duarte-Franco E, et al. The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia. Cancer Detect Prev 2005; 29:307-16.
12. Schlecht NF, Kulaga S, Robitaille J, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001; 286:3106-14.
13. Richardson H, Kelsall G, Tellier P, et al. The natural history of type-specific HPV infections in female university students. Cancer Epidemiol Biomarkers Prev 2003; 12:485-90.
14. Gravitt P, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38:357-61.
15. Aho J, Hankins C, Tremblay C, et al. Molecular analysis of human papillomavirus type 52 isolates detected in the genital tract of human immunodeficiency virus-seropositive and -seronegative women. J Infect Dis 2003; 188:1517-27.
16. Cole ST, Streek RE. Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer. J Virol 1986; 58:991-5.
17. Stewart AC, Eriksson AM, Manos MM, et al. Intratype variation in 12 human papillomavirus types: a worldwide perspective. J Virol 1996; 70:3127-36.
18. Xin CY, Matsumoto K, Yoshikawa H, et al. Analysis of E6 variants of human papillomavirus type 33, 52 and 58 in Japanese women with cervical intraepithelial neoplasia/cervical cancer in relation to their oncogenic potential. Cancer Lett 2001; 170:19-24.
19. Yamada T, Manos MM, Peto J, et al. Human papillomavirus type 16 sequence variation in cervical cancers- a worldwide perspective. J Virol 1997; 71:2463-72.
20. Heinzel PA, Chan SY, Ho L, et al. Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J Clin Microbiol 1995; 33:1746-54.
21. Ong CK, Chan SY, Campo MS, et al. Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol 1993; 67:6424-31.
22. Ho L, Chan SY, Burk RD, et al. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J Virol 1993; 67:6413-23.
23. Calleja-Macias IE, Villa LL, Prado JC, et al. Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52, and 58, four close relatives of human papillomavirus type 16. J Virol 2005; 79:13630-40.
24. Chan KS, Lam C-W, Cheung TK, et al. Association of human papillomavirus type 58 variant with the risk of cervical cancer. J Natl Cancer Inst 2002; 94:1249-53.
25. Gagnon S, Hankins C, Tremblay C, et al. Polymorphism of human papillomavirus type 31 isolates infecting the genital tract of HIV-seropositive and HIV-seronegative women at risk for HIV infection. J Med Virol 2005; 75:213-21.
26. Nindl I, Rindfleisch K, Lotz B, Schneider A, Durst M. Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer. Int J Cancer 1999; 82:203-7.
27. Zehbe I, Wilander E, Delius H, Tommasino M. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 1998; 58:829-33.
28. Zehbe I, Voglino G, Delius H, Wilander E, Tommasino M. Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms. Lancet 1998; 352:1441-2.
29. Chan PK, Lam CW, Cheung TH, et al. Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in southern China. J Infect Dis 2002; 186:696-700.
30. Giannoudis A, van Duin M, Snijders PJF, Herrington CS. Variation in the E2-binding domain of HPV 16 is associated with high-grade squamous intraepithelial lesions of the cervix. Br J Cancer 2001; 84:1058-63.
31. Calleja-Macias IE, Kalantari M, Huh J, et al. Genomic diversity of human papillomavirus-16, 18, 31, and 35 isolates in a Mexican population and relationship to European, African, and Native American variants. Virology 2004; 319:315-23.
32. Chan S-Y, Ho L, Ong C-K, et al. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol 1992; 66:2057-66.
33. Luo X, Sawadogo M. Antiproliferative properties of the USF family of helix-loop-helix transcription factors. Proc Natl Acad Sci USA 1996; 93:1308-13.
34. Xi LF, Koutsky LA, Galloway DA, et al. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 1997; 89:796-802.
35. Veress G, Szarka K, Dong XP, Gergely L, Pfister H. Functional significance of sequence variation in the E2 gene and the long control region of human papillomavirus type 16. J Gen Virol 1999; 80:1035-43.
36. Hildesheim A, Schiffman M, Bromley C, et al. Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst 2001; 93:315-8.
37. Desaintes C, Demeret C. Control of papillomavirus DNA replication and transcription. Semin Cancer Biol 1996; 7:339-47.
38. Kammer C, Warthorst U, Torrez-Martinez N, Wheeler CM, Pfister H. Sequence analysis of the long control region of human papillomavirus type 16 variants and functional consequences for P97 promoter activity. J Gen Virol 2000; 81:1975-81.
39. Watts KJ, Thompson CH, Cossart YE, Rose BR. Sequence variation and physical state of human papillomavirus type 16 cervical cancer isolates from Australia and New Caledonia. Int J Cancer 2002; 97:868-74.
40. Watts KJ, Thompson CH, Cossart YE, Rose BR. Variable oncogene promoter activity of human papillomavirus type 16 cervical cancer isolates from Australia. J Clin Microbiol 2001; 39:2009-14.
41. Sichero L, Franco EL, Villa LL. Different P105 promoter activities among natural variants of human papillomavirus type 18. J Infect Dis 2005; 191:739-42.
42. Dong XP, Stubenrauch F, Beyerfinkler E, Pfister H. Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers. Int J Cancer 1994; 58:803-8.
43. Aho J, Hankins C, Tremblay C, et al. Genomic polymorphism of human papillomavirus type 52 predisposes toward persistent infection in sexually active women. J Infect Dis 2004; 190:46-52.
44. Nakagoshi H, Nagase T, Kanei-Ishii C, Ueno Y, Ishii S. Binding of the c-myb proto-oncogene product to the simian virus 40 enhancer stimulates transcription. J Biol Chem 1990; 265:3479-83.
45. Mayrand MH, Coutlee F, Hankins C, et al. Detection of human papillomavirus type 16 DNA in consecutive genital samples does not always represent persistent infection as determined by molecular variant analysis. J Clin Microbiol 2000; 38:3388-93.